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Eraldo L. Zanella, Laura C. Miller,1 Kelly M. Lager, Troy T. Bigelow
Abstract. Pseudorabies virus (PRV) is the cause of Aujeszky’s disease, a disease that is significant economically for the
swine industry worldwide. A real-time polymerase chain reaction (PCR) assay based on the gB and gE genes was used to
identify PRV nucleic acid in diagnostic samples. Using virus isolation (VI) as the gold standard, the PCR assay performed well
in a variety of diagnostic matrices. Testing was conducted on 1,027 nasal swabs with the following findings: gB sensitivity:
94.6% (95% confidence interval [CI]: 92.3–96.4%), specificity: 71.0% (95% CI: 64.0–77.3%); gE sensitivity: 94.6% (95%
CI: 92.3–96.4%), specificity: 79.3% (95% CI: 72.9–84.7%). Diagnostic performance of the real-time PCR assay developed as
a testing method indicates that it is a rapid, accurate assay that can provide reliable results on clinical samples.
Key words: Pseudorabies virus; real-time polymerase chain reaction; swine.
Pseudorabies virus (PRV), also known as Aujeszky’s disease, is caused by Suid herpesvirus 1, a member of the
Alphaherpesvirinae subfamily. Pseudorabies virus is a neurotropic alphaherpesvirus that produces fatal encephalitis in
newborn pigs, respiratory disorders in fattening pigs, and
reproductive failure in sows.7 Swine are the natural host of
PRV, and most domestic animals (cattle, sheep, dogs, cats,
and goats but not horses) and many wild animals (rats, mice,
raccoons, opossums, rabbits, and several fur-bearing mammals) are susceptible to infection; death is the usual outcome
in nonnatural hosts.7 Although pseudorabies was eradicated
from the U.S. commercial pig industry in 2004, feral swine
infected with PRV can serve as a wildlife reservoir leading to
sporadic infections of domestic pigs that may live in close
contact with feral swine.4 Even though PRV isolates may
vary in pathogenicity, protection induced by commercial
PRV vaccines appears to be effective against all wild-type
PRV.7 An important factor in PRV eradication programs has
been the use of marker vaccines; for example, in the United
States, gE-deleted modified live virus vaccines with an
accompanying gE differential enzyme-linked immunosorbent assay (ELISA) were used in combination to eliminate
wild-type virus–infected swine.6
Maintenance of a PRV-free status involves surveillance
of susceptible swine. Serological testing for PRV antibody is
the most common method used for herd diagnosis; it is quite
efficient and sensitive once the animal has seroconverted.
However, this testing is insensitive during the acute stages of
the infection.5 A critical need for the current PRV surveillance program in the United States is the rapid detection of
PRV infection. Real-time polymerase chain reaction (PCR)
is a high-throughput test system that has potential to detect

PRV during the acute phase of the infection or before seroconversion. A set of 2 real-time PCR PRV assays detecting
gB and gE genes and using commercial chemistry has been
demonstrated to be very effective for the detection and differentiation of field and vaccine strains of PRV.3 The PCR
assay is designed as a dual assay with both gB and gE gene
targets: gB as a marker for PRV (field isolates, Shope strain,
and all commercial marker vaccines) and gE as indicator of
wild-type PRV (positive) or commercial marker vaccine
strain (negative), with the analytical sensitivity of each assay
about 0.1 plaque forming units per reaction.3 The aim of the
present study was to evaluate the real-time gB and gE PCR
assay for use as a diagnostic assay to detect an acute PRV
infection in experimentally infected pigs.
Conventionally raised pigs free of clinical disease were
purchased at 3 weeks of age from a herd that was negative
for Porcine reproductive and respiratory syndrome virus
and PRV. They were transported to the National Animal
Disease Center (NADC) and housed according to NADC
Institutional Animal Care and Use Guidelines. Pigs were
randomly assigned to treatment groups and acclimated to
isolation rooms for 7–10 days before beginning the experiment at 0 days postinoculation (dpi). Three PRV animal
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experiments were completed using 178 pigs to study various
aspects of PRV infection in swine (unpublished observations, 2010). The duration of the animal studies was scheduled for 28, 28, and 7 dpi for experiments 1–3, respectively.
Depending on experiment, pigs were inoculated with 1 of 4
PRV isolates or a sham inoculum, and nasal swabsa were collected at selected times to test for PRV.
Viruses used were feral swine isolate GG150-FS268b
(hereafter, FS268) isolated from the vaginal tract of a naturally infected free-range feral sow8; feral swine isolate 3CR
Ossabawc (hereafter, 3CR Os) isolated from a prepuce swab
of a “healthy” feral swine boar on Ossabaw Island, Georgia;
feral swine isolate Panther-117c (hereafter, FP-117) isolated
from a panther presumably infected via contact with feral
swine1; and a well-characterized domestic swine isolate PRV
ISUVDL4892d (hereafter, ISU4892) isolated from a case in
Iowa.9 Each virus was administered intranasally as either a
“high dose” (approximately 106.3 50% cell culture infective
dose [CCID50]) or a “low dose” (a 1,000-fold dilution of the
high dose). Each isolate was propagated once in a swine testicular (ST) cell line in a 75-cm2 plastic flask inoculated with
0.5 ml of original stock virus. Virus was allowed to adsorb
for approximately 1 hr followed by a medium change with
minimal essential medium (MEM)e and then maintained in
maintenance medium (MEM including 10% fetal bovine
serum and 50 mg/l gentamicin). When cytopathic effects
(CPEs) involved 80–90% of the monolayer (24–36 hr postinoculation) the flask was frozen and thawed twice at –80°C
before clarifying the cell culture lysate (1,000 × g for 10
min). The supernatant was stored in 0.5-ml aliquots at –80°C.
Nasal swab (NS) samples were collected in 2 ml of MEM
from 0 to 14 dpi for experiments 1 and 2 and from 0 to 7 dpi
for experiment 3 and stored at –80°C until tested for virus.
For viral DNA extraction, the sample was thawed, vortexed,
and centrifuged (652 × g, 4°C, 30 min). All viral DNA was
extracted from samples using a commercial kit.f After 4
washes, the DNA was mixed with the elution buffer and kept
at –80°C until used in the PCR reactions. Real-time PCR
assays for the detection of gB and gE genes were conducted
using commercial chemistryg as previously reported.3
Suspensions of 0.084 µg/ml gB plasmid and 0.023 µg/ml gE
plasmid3 were used as standards for the respective gB and gE
real-time PCR assays. Virus isolation (VI) was performed on
MARC (cloned African green monkey kidney cell line)-145
cells cultured at 37°C in 5% CO2 atmosphere in 24-well
plastic plates. A confluent monolayer of cells was inoculated
with 0.1 ml of filtered (0.45 µm) NS sample in a single well.
After approximately 1 hr postinoculation, the medium was
changed, and cells were incubated in maintenance medium
at 37°C in 5% CO2 atmosphere for 96 hr, with daily monitoring for development of CPE. Negative samples were blind
passed 1 time. A random sampling of PRV-positive wells
was confirmed using PCR. Although all NS samples were
tested for infectious virus using the MARC-145 cell line, NS

from experiment 1 had initially been thawed 1 time and
tested on ST cells before virus isolation on MARC-145 cells.
The sensitivity of the ST and MARC-145 cells for replicating PRV was compared using VI and PCR. For each
virus, a 20-µl volume of stock challenge virus was inoculated into a 25-cm2 tissue flask containing a monolayer of
either ST or MARC-145 cells. Approximately 1 hr postinoculation, the medium and flasks were incubated at 37°C in
5% CO2 atmosphere for 24 hr, at which time the flask was
frozen at –80°C and thawed. The lysate was collected and
clarified at 1,000 × g for 15 min, and a 0.5-ml volume of
virus solution was dispensed into 2-ml cryovial tubes for
storage at –80°C. Two vials were thawed for testing (second
freeze–thaw cycle), and 2 vials were frozen and thawed 3
additional times before testing (fifth freeze–thaw cycle).
Each isolate propagated in ST or MARC-145 cells was tested
for infectious virus by titration of the virus on ST and
MARC-145 cells. In addition, viral DNA was extracted and
tested by PCR. Serum samples collected at 0 and 14 dpi were
tested for PRV antibodies using an ELISA assay,i according
to manufacturer’s recommendations, where PRV gB ELISA
optical density sample-to-negative (S/N) ratio <0.60 is positive, S/N ratio >0.60 to ≤0.70 is suspect, and S/N ratio >0.70
is negative.
Sensitivity (Se), specificity (Sp), and kappa (κ) coefficients of agreement were calculated for the real-time PCR
assay performance compared with results of VI, the gold
standard test, using contingency tables and Fisher exact test
(2-tailed) preformed with commercial software.j,k The κ
coefficient of agreement can take values between 0 and 1,
where poor agreement κ is <0.20, fair agreement κ = 0.20–
0.39, moderate agreement κ = 0.40–0.59, good agreement
κ = 0.60–0.79, and very good agreement κ = 0.80–1.00.2
Control animals did not display clinical signs or lesions
consistent with PRV infection. The PRV-inoculated pigs
developed a spectrum of disease that ranged from mild to
severe, which required euthanasia for humane reasons.
Clinical signs observed included sneezing, anorexia, listlessness, increased respiration rates, dyspnea, rough-haired
appearance, and loss of condition. The onset, magnitude, and
duration of clinical signs were variable among pigs within a
group and between groups inoculated with different viruses
and seemed related to challenge dose (i.e., the groups that
received the “high” dose had more virus-positive and
affected pigs compared with the “low” dose groups).
Moreover, there appeared to be differences in the pathogenicity of the viruses, with the ISU4892 being the most pathogenic followed by the FP-117, 3CR Os, and FS268 isolates,
in that order. Mortality following inoculation did occur in
some groups and is reflected in the reduction of pig numbers
(decrease in the denominator) shown in Table 1.
The MARC-145 cell line was chosen for VI because 1)
the cells consistently grew better compared with ST cells in
the laboratory, making the process of VI on hundreds of
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1/7
1/2
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101/106
7/7
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1/2

4/7
100/102

5/7
7/7

gE PCR

0/7
1/2

0/7
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3/7
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PCR

1/7
1/1

2/7
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4/6
3/7
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PCR
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0/7
0/1

0/7
2/5

0/6
1/7

VI

0/7
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1/7
0/5

2/6
2/7
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PCR

0/7
1/1

1/7
0/5

1/6
2/7
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PCR
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10/10
10/10
10/10
10/10
9/10
9/10
9/10
7/10
6/10
10/10
8/10
10/10
10/10
10/10 10/10
8/10
6/10
6/10
96%
89%
91%
84%
64%
62%
38%
36%
32%
(154/161) (135/152) (138/152) (128/152) (35/53) (33/53) (20/53) (19/53) (17/53)

5/7
7/7

gB PCR

7/7
7/7

VI

7

0/5
1/1

0/7
0/5

0/6
1/7

gB
PCR

0/5
1/1

0/7
0/5

0/6
1/7

gE
PCR

3/10 0/10 0/10
5/10 0/10 0/10
15% 4%
4%
(8/53) (2/51) (2/51)

0/7
0/1

0/7
0/5

0/6
0/7

VI

14

0/10
0/10
0%
(0/51)

0/5
0/1

0/7
0/5

0/6
0/7

VI

* Entries indicate the number of positives/total number of pigs in group. FS268 = feral swine isolate GG150-FS268b isolated from the vaginal tract of a naturally infected free-range feral sow; 3CR Os =
feral swine isolate 3CR Ossabawc isolated from a prepuce swab of a “healthy” feral swine boar on Ossabaw Island, Georgia; ISU4892 = well-characterized domestic swine isolate PRV ISUVDL4892d
isolated from a case in Iowa; FP-117 = feral swine isolate Panther-117c isolated from a panther presumably infected via contact with feral swine.
† Strain 3CR Os at a high dose was also sampled at 6 dpi resulting in 93/99 (94%), 89/99 (90%), and 98/99 (99%) samples positive/total number of pigs for gB PCR, gE PCR, and VI, respectively.
‡ Percentage positive out of total tested (number positive/number tested).

FS268
Low
6/7
5/7
6/7
7/7
7/7
High
7/7
7/7
7/7
7/7
7/7
3CR Os†
Low
2/7
2/7
2/7
4/7
4/7
High 101/106
99/106
94/106
98/106
94/106
ISU4892
Low
2/7
0/7
0/7
1/7
0/7
High
5/7
5/7
5/7
7/7
7/7
FP-117
Low
4/10
4/10
5/10
9/10
8/10
High
10/10
10/10
10/10
10/10
10/10
Percent
85%
82%
80%
89%
85%
positive‡ (137/161) (132/161) (129/161) (143/161) (137/161)

Strain
dose

2

Day postinoculation when sample was collected

Table 1. Detection of Pseudorabies virus in nasal swabs by real-time polymerase chain reaction (PCR) assay and virus isolation (VI).
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Table 2. Analytical comparison of Pseudorabies virus propagation in ST (swine testicular) cell line and MARC (cloned African green
monkey kidney cell line)-145 cells by virus titration and by virus isolation via real-time polymerase chain reaction assay on ST or MARC145 cells.*
MARC-145
FP-117
F-T 2
F-T 5
3CR Os
F-T 2
F-T 5
FS268
F-T 2
F-T 5
ISU4892
F-T 2
F-T 5

ST

MARC-145

ST

MARC-145†

ST

MARC-145

ST

gB‡

gE

gB

gE

7.12
6.63

5.58
5.42

6.88
6.58

5.70
5.50

4.48
5.25

5.22
5.89

5.01
5.59

5.52
6.20

6.12
5.62

5.42
4.47

6.12
5.58

5.63
4.12

4.42
4.62

4.86
5.02

4.80
5.21

5.08
5.57

7.16
5.42

5.58
5.30

4.88
3.58

4.30
3.16

4.63
4.95

5.22
5.39

4.34
4.66

4.76
4.78

7.16
6.50

6.58
6.30

6.30
4.88

5.58
4.50

5.09
5.54

5.67
6.00

4.99
5.75

5.53
6.11

* Two vials were thawed for testing (F-T 2) and 2 vials were frozen and thawed 3 additional times before testing (F-T 5). Sham samples at second and fifth
freeze–thaw cycles were negative in all tests. FP-117 = feral swine isolate Panther-117c isolated from a panther presumably infected via contact with feral
swine; 3CR Os = feral swine isolate 3CR Ossabawc isolated from a prepuce swab of a “healthy” feral swine boar on Ossabaw Island, Georgia; FS268 =
feral swine isolate GG150-FS268b isolated from the vaginal tract of a naturally infected free-range feral sow; ISU4892 = well-characterized domestic swine
isolate PRV ISUVDL4892d isolated from a case in Iowa.
† log10 50% cell culture infective dose/100 µl.
‡ log10 copy number/100 µl.

samples much more efficient; 2) PRV infection of MARC145 cells induced a dramatic CPE consisting of large formations of syncytia that were easily observed; and 3) under the
conditions of the current study, the MARC-145 cells were as
sensitive or more so for PRV isolation compared with ST
cells (Table 2). Compared with ST cells, the CPE for each
PRV isolate that developed in MARC-145 cells following
inoculation was more rapid and extensive by 24 hr, the time
of freezing for each flask. However, the viral titers produced
in either cell line were similar for each virus despite the cell
line in which the virus was propagated (Table 2). Likewise,
the quantitative PCR results were similar for viruses produced in ST or MARC-145 cells (Table 2). A suspension of
field isolate PRV strains FS268, 3CR Os, and ISU4892, and
plasmid, as well as serial dilutions in MEM, were tested in
duplicate to determine real-time PCR assay sensitivity
(Table 3). The real-time PCR assay was able to detect a
range of positive dilutions (up to 10-5 using MEM as diluent). Concentrations of 102.2 CCID50/ml FS268, 101.7 CCID50/
ml 3CR Os, and 101.9 CCID50/ml ISU4892 were detected
(Table 4). Because of the small size of the PCR product,
sequencing was not performed; however, size of the product
was consistent among samples tested. In general, the gB
threshold cycle values were lower than those from the gE
PCR. A sample was classified positive if at least 1 duplicate
tested positive for the following gB or gE PCR results.
A total of 1,027 NS were collected from 0 to 14 dpi and
tested for infectious virus; 136 NS were from 17 control pigs
and 891 NS were from PRV-inoculated pigs. All samples

Table 3. Detection limits and threshold cycle (Ct) values of
real-time polymerase chain reaction assay for Pseudorabies virus
standards.
Ct value
gB copy per reaction
5.75 × 107
5.75 × 106
5.75 × 105
5.75 × 104
5.75 × 103
5.75 × 102
5.75 × 101
gE copy per reaction
1.63 × 108
1.63 × 107
1.63 × 106
1.63 × 105
1.63 × 104
1.63 × 103
1.63 × 102
1.63 × 101
1.63 × 100
1.63 × 10-1

17.2
19.9
23.1
26.5
30.3
33.6
36.6
14.7
15.1
17.1
19.8
23.0
25.4
29.5
33.5
38.6
Undetected

from control pigs and the 0 dpi NS collected from the PRVinoculated pigs were negative for infectious virus, a total of
297 NS samples (data not shown). Pseudorabies virus was

Real-time PCR assay for Pseudorabies virus
Table 4. Detection limits and threshold cycle (Ct) values of
real-time polymerase chain reaction assay for Pseudorabies virus
field samples.

Strain
FS268

3CR Os

ISU4892

Ct value

Infectious virus per
reaction (CCID50)

gB

gE

40
4
0.4
0.04
12.5
1.25
0.125
0.0125
19.8
1.98
0.198
0.0198

30.9
34.5
38.6
Undetected
31.2
34.7
38.2
Undetected
31.6
35.4
38.8
Undetected

28.8
32.5
36.0
39.2
29.5
33.2
36.7
Undetected
29.7
33.3
37.7
Undetected

* FS268 = feral swine isolate GG150-FS268b isolated from the vaginal
tract of a naturally infected free-range feral sow; 3CR Os = feral swine
isolate 3CR Ossabawc isolated from a prepuce swab of a “healthy” feral
swine boar on Ossabaw Island, Georgia; ISU4892 = well-characterized
domestic swine isolate PRV ISUVDL4892d isolated from a case in Iowa;
CCID50 = 50% cell culture infective dose; undetected = no signal for a
cycle threshold below 40.

isolated from 537 of the 730 NS collected 2–14 dpi from the
161 PRV-inoculated pigs (Table 1). The incidence of positive NS ranged from 80% at 2 dpi to 0% at 14 dpi with a peak
of 99% at 6 dpi (Table 1). When individual challenge groups
were compared, the incidence of positive NS was similar
among groups, with apparent differences related to challenge
dose. Due to relatively small animal numbers in some of the
groups, statistical analysis was not applied to the incidence
of positive NS among groups.
A total of 1,027 NS were tested with the gB and gE realtime PCR assays. For VI, 136 NS were from 17 control pigs
and 891 NS were from PRV-inoculated pigs. All samples
from control pigs tested negative by the gB and gE assays.
One of the 161 NS samples collected from the PRVinoculated pigs at 0 dpi tested positive by gB and gE, and the
remaining 160 NS samples at 0 dpi tested negative by both
gB and gE assays. Collectively, 296 of the 297 NS samples
collected from the control pigs and the PRV-inoculated pigs
at 0 dpi were negative by PCR (data not shown). The single
PCR-positive 0 dpi sample that tested positive by gB and gE
retested positive by the gB and gE assays and was negative
by VI. Of the NS collected from 2 to 14 dpi from the PRVinoculated pigs, 564 of 730 and 548 of 730 samples tested
positive by the gB and gE assays, respectively (Table 1).
To evaluate the Se, Sp, and κ agreement for the gB and gE
PCR assays, VI was used as the gold standard test. Overall,
73.6% of the swab samples tested positive by VI, and 77.3%
and 75.1% tested positive by the gB and gE PCR assays,
respectively. The Se, Sp, and κ values (Table 5) show a good
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Table 5. Overall results, sensitivity (Se), specificity (Sp), and
kappa (κ) degree of agreement for real-time polymerase chain
reaction (PCR) assay versus virus isolation (VI) for Pseudorabies
virus collected by nasal swab.*
VI
Test
gB PCR
+
–
Total
Se
Sp
κ
gE PCR
+
–
Total
Se
Sp
κ

+

–

Total

508
29
537

56
564
137
166
193
730
94.6% (95% CI: 92.3–96.4%)
71.0% (95% CI: 64.0–77.3%)
0.687 (0.625–0.748)

508
29
537

40
548
153
182
193
730
94.6% (95% CI: 92.3–96.4%)
79.3% (95% CI: 72.9–84.7%)
0.752 (0.697–0.808)

* + = positive; – = negative; 95% CI = 95% confidence interval.

agreement between the assays despite a higher percentage of
positive samples in the PCR assays compared with VI. Most
of the difference between the PCR-positive and VI-positive
samples was detected at 9–14 dpi, with more samples being
PCR positive than VI positive (Table 1). This is in contrast to
2–7 dpi, where more samples were VI positive than PCR
positive, indicating a higher likelihood to isolate virus during
the first week postchallenge compared with the second week.
Based on the ELISA, all PRV-inoculated pigs were seropositive by 14 dpi (mean S/N 0.26 ± 0.2) All control pigs for
the duration of the study as well as all 0 dpi sera were negative (mean S/N 1.22 ± 0.03) for PRV gB antibody.
A variety of methods can be used to detect PRV infection
in swine. Selecting a method or methods to use may be based
on a number of factors (e.g., available equipment and
reagents, the need to detect acute or chronic infections, and
the necessity to screen large numbers of samples for antibody, antigen, infectious virus, or viral nucleic acid). In
PRV-free swine herds, detection of antibody is a very efficient and reliable tool to monitor PRV status.7 A limitation
of this type of testing is the potential to miss positive animals
because they have not yet seroconverted. The potential of a
real-time PCR test to detect PRV during the acute phase of
infection was evaluated at a time when pigs would be developing a humoral response and thus would be seronegative by
currently available antibody tests.
The acute nature of the PRV infection observed in experiments 1–3 is demonstrated in Table 1 with isolation of infectious PRV by 2 dpi in most inoculated pigs and in 99% of the
pigs at 6 dpi. The incidence of VI-positive pigs decreased to
0% by 14 dpi, a time when all surviving animals have become
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antibody positive. The incidence of PCR-positive pigs mirrors the VI data with slight temporal differences in which
the incidence of VI-positive pigs is similar to or greater than
PCR-positive pigs during the first week of infection and the
incidence of PCR-positive pigs is greater than VI-positive
pigs during the second week of the infection.
Real-time PCR assays have been developed and standardized for the detection of wild-type PRV using the gB gene
target and the gE gene to differentiate from vaccine virus.3 In
the present study, the real-time PCR assays were evaluated
for diagnostic and surveillance potential and showed a high
sensitivity that detected the viral genome in every inoculated
pig. Utilization of a real-time PCR assay eliminates the
requirement of separate amplification and detection reactions associated with gel-based techniques. Compared with
conventional PCR, real-time PCR assays based on fluorogenic probes have additional advantages, including improved
sensitivity that is based on very short amplification products
and results in increased specificity, simultaneous detection
of relevant PCR products using multichannel analysis, and
reduction of cross-contamination through absence of postPCR handling of product.
The higher sensitivity of the real-time PCR assays compared with VI assays was demonstrated in the present study.
The real-time PCR assay as described3 detected a number of
various PRV strains including feral and domestic from different geographical regions. The potential for false-positive
or false-negative results is a risk associated with any
amplification-based assay, including real-time PCR. In the
current study, 1 PCR false-positive was easily detected
because it was found in a sample collected at 0 dpi. This
sample was still positive by both PCR assays upon retest but
was negative by VI. Although it is not known why this sample was PCR positive, a technical mistake is presumed to
have been made (i.e., a mistake in tube labeling). Nevertheless,
there was 1 known PCR-positive sample of 298 samples that
should have all been negative because they were either collected from nonchallenge control pigs or collected prior to
challenge (0 dpi) in the challenge pig groups. It is not possible to assess the potential for false-positive results in the
PRV-challenged pigs because all pigs were considered positive (i.e., virus was isolated [gold standard] at least 1 time
from each challenge pig, at least 1 NS sample was PCR positive for each pig, and all pigs alive at 14 dpi were seropositive). Although each PRV-inoculated pig was deemed PRV
positive, not all samples tested from each pig were positive
(Table 1). It is believed that the detection of negative samples in the virus-challenged animals reflects more upon the
host response to the disease and not a false-negative rate of
approximately 25% overall.
Collectively, results from these studies indicate that
natural infection of domestic swine with feral swine PRV
isolates should be detected either through detection of
virus during the acute phase of the infection or through
detection of antibody in the convalescent phase of the

infection. This conclusion supports many current control
programs that screen sera for PRV-specific antibody and
that may consider incorporating testing tissues for virus by
real-time PCR.
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